X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30) 30
index medicus (24) 24
male (22) 22
female (18) 18
aged (12) 12
adult (11) 11
bandages, dressings or absorbent pads (11) 11
devices providing patency to, or preventing collapsing of,tubular structures of the body, e.g. stents (11) 11
filters implantable into blood vessels (11) 11
first-aid kits (11) 11
fomentation (11) 11
human necessities (11) 11
hygiene (11) 11
medical or veterinary science (11) 11
middle aged (11) 11
orthopaedic, nursing or contraceptive devices (11) 11
prostheses (11) 11
treatment or protection of eyes or ears (11) 11
medicine & public health (8) 8
aged, 80 and over (7) 7
animals (7) 7
biochemistry & molecular biology (7) 7
internal medicine (7) 7
oxidative stress (7) 7
biology (6) 6
disease (6) 6
medicine (6) 6
mortality (6) 6
clinical neurology (5) 5
emergency department (5) 5
lipids (5) 5
alexithymia (4) 4
antiviral agents - therapeutic use (4) 4
depression (4) 4
disability (4) 4
drug therapy (4) 4
fatty acids (4) 4
gastroenterology & hepatology (4) 4
mutation (4) 4
oncology (4) 4
predictive value of tests (4) 4
prevalence (4) 4
research article (4) 4
ribavirin (4) 4
risk factors (4) 4
severity of illness index (4) 4
abridged index medicus (3) 3
age factors (3) 3
alleles (3) 3
alzheimer's disease (3) 3
analysis (3) 3
anesthesiology and pain medicine (3) 3
antiviral agents - adverse effects (3) 3
biomarkers - blood (3) 3
blood (3) 3
care and treatment (3) 3
case-control studies (3) 3
comorbidity (3) 3
delirium (3) 3
depression, mental (3) 3
diagnosis (3) 3
fatty acids - metabolism (3) 3
geriatrics & gerontology (3) 3
hepatitis c (3) 3
hepatitis c virus (3) 3
hepatitis c, chronic - drug therapy (3) 3
hepatocellular carcinoma (3) 3
italy (3) 3
italy - epidemiology (3) 3
lipid metabolism (3) 3
lipid peroxidation (3) 3
liver - metabolism (3) 3
liver - pathology (3) 3
logistic models (3) 3
medical research (3) 3
medicine, experimental (3) 3
medicine, general & internal (3) 3
mice (3) 3
migraine (3) 3
neurology (3) 3
non-alcoholic fatty liver disease - metabolism (3) 3
oxidation-reduction (3) 3
oxysterols (3) 3
oxysterols - metabolism (3) 3
pain medicine (3) 3
prognosis (3) 3
prospective studies (3) 3
repeaters (3) 3
risk (3) 3
surgery (3) 3
sustained virological response (3) 3
treatment outcome (3) 3
4at (2) 2
5α, 6α-epoxy, 5α,6α-epoxycholesterol (2) 2
5β, 6β-epoxy, 5β,6β-epoxycholesterol (2) 2
6-oxo, 6-oxo-cholestan-3β,5α-diol (2) 2
7β-ohc, 7β-hydroxycholesterol (2) 2
activation (2) 2
aged patients (2) 2
aging (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, p. e0167934
Background Novel direct-acting antivirals (DAAs) have completely changed the panorama of hepatitis C due to their high efficacy and optimal safety profile.... 
ANGIOGENESIS | EFFICACY | SOFOSBUVIR | CIRRHOSIS | MULTIDISCIPLINARY SCIENCES | C VIRUS-INFECTION | GENE-EXPRESSION | RIBAVIRIN | HEPATITIS-C | LEDIPASVIR | ENDOTHELIAL GROWTH-FACTOR | Hepatitis C - drug therapy | Human Umbilical Vein Endothelial Cells - metabolism | Humans | Middle Aged | Tumor Necrosis Factor-alpha - blood | Vascular Endothelial Growth Factor A - blood | Interleukin-10 - blood | Male | Antiviral Agents - administration & dosage | Epidermal Growth Factor - blood | Hepacivirus - metabolism | Inflammation - blood | Neoplasms | Inflammation - drug therapy | Antiviral Agents - adverse effects | Hepatitis C - blood | Aged, 80 and over | Adult | Female | Aged | Cell Proliferation - drug effects | Antiviral agents | Complications and side effects | Liver cancer | Hepatitis C | Drug therapy | Vascular endothelial growth factor | Health aspects | Risk factors | Therapy | Interleukin | Hepatocellular carcinoma | Infections | Cancer therapies | Hepatitis | Angiogenesis | Biological effects | Cell growth | Epidermal growth factor | Interleukins | Hepatology | Pretreatment | Immune system | Liver diseases | Cytokines | Internal medicine | Inflammation | Tumor necrosis factor-α | Gene expression | Patients | Endothelial cells | Medicine | Hypotheses | Interleukin 10 | Interferon | Hepatitis C virus | Umbilical vein | Viral infections
Journal Article
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 01/2019, Volume 20, Issue 1, p. 49
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 10/2017, Volume 111, pp. 173 - 185
Non-alcoholic fatty liver disease (NAFLD) is the major public health challenge for hepatologists in the twenty-first century. NAFLD comprises a histological... 
Lipid peroxidation | Lipid metabolism | Non-alcoholic steatohepatitis | Oxysterols | ACETYL-COA | DE-NOVO LIPOGENESIS | FATTY LIVER-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | STEAROYL-COA DESATURASE-1 | ACTIVATED RECEPTOR-ALPHA | ENDOPLASMIC-RETICULUM STRESS | NUCLEAR RECEPTOR | INSULIN-RESISTANCE | ENDOCRINOLOGY & METABOLISM | HEPATIC STEATOSIS | ANTISENSE OLIGONUCLEOTIDE INHIBITORS | Non-alcoholic Fatty Liver Disease - pathology | Liver - pathology | Oxidative Stress | Humans | Cytochrome P-450 Enzyme System - metabolism | Non-alcoholic Fatty Liver Disease - complications | Fatty Acid Transport Proteins - metabolism | Liver Cirrhosis - metabolism | Lipid Metabolism - genetics | Fatty Acids - metabolism | Liver Cirrhosis - genetics | Oxysterols - metabolism | Severity of Illness Index | Liver Cirrhosis - etiology | Nuclear Receptor Coactivators - metabolism | Non-alcoholic Fatty Liver Disease - genetics | Oxidation-Reduction | Liver - metabolism | Gene Expression Regulation | Insulin Resistance | Non-alcoholic Fatty Liver Disease - metabolism | Cholesterol - metabolism | Disease Progression | Cytochrome P-450 Enzyme System - genetics | Liver Cirrhosis - pathology | Nuclear Receptor Coactivators - genetics | Fatty Acid Transport Proteins - genetics | Medical research | Bile acids | Liver | Low density lipoproteins | Cytochrome P-450 | Lipids | Transforming growth factors | Aldehydes | Fatty acids | Carnitine | Monounsaturated fatty acids | Synthesis | Physiological aspects | Medicine, Experimental | Insulin resistance | Oxidation-reduction reaction | Liver cirrhosis | Saturated fatty acids | Protein binding
Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 11/2019, Volume 26, Issue 11, pp. 1249 - 1256
The advent of highly effective and well‐tolerated direct antiviral antivirals (DAAs) has dramatically changed the landscape of chronic hepatitis C. The effect... 
older adults | viral hepatitis | direct‐acting antivirals | hepatitis C | Antiviral agents | Medical research | Care and treatment | Analysis | Medicine, Experimental | Aged patients | Hepatitis C virus | Hepatitis C
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2017, Volume 59, Issue 2, pp. 615 - 631
Journal Article
Frontiers in Pharmacology, ISSN 1663-9812, 09/2019, Volume 10
Besides the memory impairment, Alzheimer’s disease (AD) is often complicated by neuropsychiatric symptoms also known as behavioral and psychological symptoms... 
serotonin | depression | Alzheimer’s disease | selective serotonin reuptake inhibitors | amyloid-β peptide | tricyclic antidepressants
Journal Article
Free Radical Biology and Medicine, ISSN 0891-5849, 10/2017, Volume 111, pp. 281 - 293
4-hydroxy-2-nonenal (HNE) is considered to be a strong marker of oxidative stress; the interaction between HNE and cellular proteins leads to the formation of... 
Parkinson's disease | bipolar disorders | neuropsychiatric disorders | depression | schizophrenia | Huntington's disease | 4-hydroxy-2-nonenal | OXIDATIVE STRESS | ANTERIOR CINGULATE CORTEX | LEVODOPA-INDUCED DYSKINESIAS | BIOCHEMISTRY & MOLECULAR BIOLOGY | ALDEHYDE DEHYDROGENASE 2 | ALPHA-SYNUCLEIN | BIPOLAR DISORDER | GAMMA-GLUTAMYL-TRANSPEPTIDASE | ENDOCRINOLOGY & METABOLISM | MITOCHONDRIAL DYSFUNCTION | HUNTINGTONS-DISEASE | PARKINSONS-DISEASE | Neuroprotective Agents - therapeutic use | Bipolar Disorder - metabolism | Schizophrenia - metabolism | Oxidative Stress | Substantia Nigra - pathology | Depressive Disorder, Major - metabolism | Humans | Huntington Disease - pathology | Cerebral Cortex - pathology | Parkinson Disease - drug therapy | Schizophrenia - pathology | Substantia Nigra - metabolism | Aldehydes - metabolism | Molecular Targeted Therapy | Aldehydes - antagonists & inhibitors | Cerebral Cortex - metabolism | Parkinson Disease - metabolism | Cerebral Cortex - drug effects | Huntington Disease - drug therapy | Depressive Disorder, Major - drug therapy | Depressive Disorder, Major - pathology | Parkinson Disease - pathology | Mitochondria - metabolism | Mitochondria - drug effects | Mitochondria - pathology | Bipolar Disorder - drug therapy | Huntington Disease - metabolism | Iron - metabolism | Substantia Nigra - drug effects | Bipolar Disorder - pathology | Schizophrenia - drug therapy | Lipid Peroxidation | Schizophrenia | Lipid peroxidation | Cellular proteins | Bipolar disorder | Nervous system diseases | Depression, Mental
Journal Article